OXFORD BIOMEDICA (OXB): MODERATED CHART AND DISCUSSION THREAD

G`Day from NZ
Wishing everyone a Happy Xmas.
Elfman - yes we have noted you haven't bee posting much recently but I guess you have been busy helping out Santa deliver the presents
Got a lovely rack of lamb for the BBQ for the big day but will be having the obligatory turkey tomorrow.
I will be back for Tuco's 50p party and perhaps later in the year we need a host and venue for the £1 party.....what about the Emirates stadium CFC??;)
As my final point, I see a hostile takeover as highly likely....it is the BREADTH of products that to me is the single strongest card in OXB's hand. Trovax will be proven to be a safe drug with significant improvements in outcome and hence it will be approved by NICE but on its merits alone is not a world beater (since it has not yet been defined by its phase 3 results -the ONE thing that truly counts). Prosavin has huge potential but is only a "cure" in severe late stage disease. Lentivector is just getting bigger and bigger. Retinostat will be the market leader in terms of frequency of application etc etc All very very good, none (at this stage), of the scale of a new "Zantac" etc
My point is, the sum of the parts is greater than the whole IMO

4ft and clean outside so cheerio....